… managing medication burden in older patients with metastatic prostate cancer,” … of an oral ARSI (abiraterone, enzalutamide, or apalutamide) … between ARSIs and other drug classes, which could … metastatic prostate cancer. However, the complexity of treatment may …

… castration-sensitive prostate cancer (mCSPC). The … treatment intensity with patient tolerability, and integrating emerging evidence from pivotal trials … coupled with minimal drug–drug interactions, makes … (Xtandi), and abiraterone acetate (Zytiga)—featured …

… inhibitors (ARPIs) ARPIs influence both drug selection and patient monitoring. While … translate into practical care pathways. Abiraterone demands vigilance for hypertension, hypokalemia … how tailoring monitoring to each drug’s profile enhances both outcomes …

… ARANOTE trial for mHSPC? Cora N. Sternberg, MD: [In terms of] treatment … .fda.gov/drugs/;resources-information-approved-drugs/fda-approves-darolutamide-metastatic-castration-sensitive-prostate-cancer …

… CAPItello-281 trial, combining capivasertib (Truqap) with abiraterone acetate, … refused cisplatin-based chemotherapy following treatment with perioperative enfortumab … sensitive prostate cancer (PSMAddition). Presented at European Society for Medical Oncology …

… Breast02 trial, which evaluated Datroway versus chemotherapy as a first-line treatment … abiraterone and androgen deprivation therapy in PTEN-deficient metastatic hormone-sensitive prostate cancer … to commercial medicine as opposed to being on free drug that …

… is a leading FDA-approved treatment for NMOSD with growth … patients with chemotherapy-naive metastatic castrate-resistant prostate cancer. We are … for patients and doctors on a statin, but with inadequate … on lower Medicare pricing for obesity drugs. I’d …

… experience running clinical trials in large population. … treatment for patients with locally advanced metastatic urothelial cancer. Our vaccines … is post abiraterone metastatic hormone-resistant prostate cancer, and that … trial you guys initiated on an oral drug …

… FDA approved TEZSPIRE for the add-on maintenance treatment … prostate cancer (mCRPC) who have previously been treated with taxane-based chemotherapy … in combination with abiraterone is ongoing in … to establish the biotechnology industry and remains on …

… for Gemcitabine lyophilised injection, Abiraterone, Imatinib, and Capecitabine tablets … capabilities in high-quality drug development. These approvals pave … range of cancers, including gastrointestinal, colon, rectal, pancreatic, prostate, bladder, …